GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes. [PDF]
J Am Geriatr SocChen JC +4 more
europepmc +1 more source
Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy. [PDF]
Amino AcidsFajkić A, Lam YW, Belančić A.
europepmc +1 more source
Added Value to GLP-1 Receptor Agonist: Intermittent Fasting and Lifestyle Modification to Improve Therapeutic Effects and Outcomes. [PDF]
BiomedicinesCozma D, Văcărescu C, Stoicescu C.
europepmc +1 more source
Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia. [PDF]
Skin Appendage DisordAlharbi S, Alkhalifah A.
europepmc +1 more source
Various GLP-1 Receptor Agonist Preference Use with a Special Focus on Oral and Subcutaneous Forms in Poland. [PDF]
Healthcare (Basel)Nowak K +7 more
europepmc +1 more source
Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients: Experience-Based Considerations. [PDF]
Aesthet Surg J Open ForumMoradi A +4 more
europepmc +1 more source
Real-World Use of GLP-1 Receptor Agonist Liraglutide in Adolescents with Obesity: A First Longitudinal Single-Center Analysis from Switzerland. [PDF]
Children (Basel)Noordam C +4 more
europepmc +1 more source
Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy. [PDF]
Dermatol Ther (Heidelb)Moradi A +4 more
europepmc +1 more source